Dicerna Pharmaceuticals
DRNA
#3910
Rank
A$4.25 B
Marketcap
A$54.56
Share price
0.00%
Change (1 day)
15,592.16%
Change (1 year)

Market capitalization of Dicerna Pharmaceuticals (DRNA)

Last known market cap: A$4.25 Billion

As of March 2026 Dicerna Pharmaceuticals has a market cap of A$4.25 Billion. This makes Dicerna Pharmaceuticals the world's 3910th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dicerna Pharmaceuticals from 2014 to 2022

End of year Market Cap

Year Marketcap Change
2022A$4.37 B6.54%
2021A$4.10 B89.24%
2020A$2.17 B-3.62%
2019A$2.25 B117.58%
2018A$1.03 B73.29%
2017A$0.59 B620.38%
2016A$82.91 M-75.29%
2015A$0.33 B-6.25%
2014A$0.35 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$215.75 B 4,975.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$281.80 B 6,529.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$408.02 B 9,499.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
A$0.80 B-81.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$59.33 B 1,295.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$11.00 B 158.88%๐Ÿ‡บ๐Ÿ‡ธ USA